Thomas Agoritsas

@thomasagoritsas.bsky.social

⚕️Physician & Prof🇨🇭🇬🇷🇫🇷 Geneva University Hospitals • McMasterU 🇨🇦 • Chair of MagicEvidence.org 🌍 • https://www.unige.ch/medecine/demed/recherche/thomas-agoritsas • Publications: https://scholar.google.com/citations?user=uoVzMm4AAAAJ&hl=en • Own 🦋

Compare the benefits and harms of drugs for obesity in our large network meta-analysis (262 trials including almost 100K patients). Some surprising results, such as as the effects on quality of life at 1 year. Have a look ! 👇

The BMJ@bmj.com · 4w ago

Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life and few show cardiovascular benefits at one year, finds a new study in The BMJ https://bit.ly/4gmXim6 Read the linked commentary https://bit.ly/4f67A7I